Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Option Care Health (OPCH) EBITDA (2016 - 2025)

Option Care Health (OPCH) has disclosed EBITDA for 17 consecutive years, with $57.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA fell 7.41% year-over-year to $57.1 million, compared with a TTM value of $200.6 million through Dec 2025, down 3.49%, and an annual FY2025 reading of $200.6 million, down 3.49% over the prior year.
  • EBITDA was $57.1 million for Q4 2025 at Option Care Health, up from $50.4 million in the prior quarter.
  • Across five years, EBITDA topped out at $117.7 million in Q2 2023 and bottomed at $1.2 million in Q1 2021.
  • Average EBITDA over 5 years is $49.6 million, with a median of $47.9 million recorded in 2022.
  • The sharpest move saw EBITDA soared 3288.93% in 2022, then tumbled 55.7% in 2024.
  • Year by year, EBITDA stood at $75.0 million in 2021, then plummeted by 41.11% to $44.2 million in 2022, then grew by 15.66% to $51.1 million in 2023, then grew by 20.71% to $61.7 million in 2024, then decreased by 7.41% to $57.1 million in 2025.
  • Business Quant data shows EBITDA for OPCH at $57.1 million in Q4 2025, $50.4 million in Q3 2025, and $48.8 million in Q2 2025.